RAPTOR PHARMACEUTICAL CORP's ticker is and the CUSIP is 75382F956. A total of 2 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $75,000 | -22.7% | 14,000 | -25.1% | 0.00% | – |
| Q4 2015 | $97,000 | -63.7% | 18,700 | -57.6% | 0.00% | – |
| Q3 2015 | $267,000 | -82.2% | 44,100 | -53.5% | 0.00% | -100.0% |
| Q2 2015 | $1,498,000 | +141.6% | 94,900 | +66.5% | 0.00% | 0.0% |
| Q1 2015 | $620,000 | +155.1% | 57,000 | +146.8% | 0.00% | – |
| Q4 2014 | $243,000 | +161.3% | 23,100 | +138.1% | 0.00% | – |
| Q3 2014 | $93,000 | -33.6% | 9,700 | -19.8% | 0.00% | – |
| Q2 2014 | $140,000 | -54.5% | 12,100 | -60.7% | 0.00% | – |
| Q1 2014 | $308,000 | -28.4% | 30,800 | -6.7% | 0.00% | -100.0% |
| Q4 2013 | $430,000 | +900.0% | 33,000 | +1037.9% | 0.00% | – |
| Q3 2013 | $43,000 | +115.0% | 2,900 | +38.1% | 0.00% | – |
| Q2 2013 | $20,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 672,100 | $6,445,000 | 0.10% |
| Citadel Advisors | 9,700 | $93,000 | 0.00% |